These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 37686121)

  • 1. Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors.
    Bokhari SMZ; Hamar P
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis.
    Achen MG; Williams RA; Minekus MP; Thornton GE; Stenvers K; Rogers PA; Lederman F; Roufail S; Stacker SA
    J Pathol; 2001 Feb; 193(2):147-54. PubMed ID: 11180159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
    Lohela M; Bry M; Tammela T; Alitalo K
    Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro.
    Marconcini L; Marchio S; Morbidelli L; Cartocci E; Albini A; Ziche M; Bussolino F; Oliviero S
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9671-6. PubMed ID: 10449752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas.
    Jenny B; Harrison JA; Baetens D; Tille JC; Burkhardt K; Mottaz H; Kiss JZ; Dietrich PY; De Tribolet N; Pizzolato GP; Pepper MS
    J Pathol; 2006 May; 209(1):34-43. PubMed ID: 16523449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.
    Achen MG; Roufail S; Domagala T; Catimel B; Nice EC; Geleick DM; Murphy R; Scott AM; Caesar C; Makinen T; Alitalo K; Stacker SA
    Eur J Biochem; 2000 May; 267(9):2505-15. PubMed ID: 10785369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy.
    Hsu JY; Wakelee HA
    BioDrugs; 2009; 23(5):289-304. PubMed ID: 19754219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer.
    Achen MG; Williams RA; Baldwin ME; Lai P; Roufail S; Alitalo K; Stacker SA
    Growth Factors; 2002 Jun; 20(2):99-107. PubMed ID: 12148568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab.
    Moehler M; Frings C; Mueller A; Gockel I; Schimanski CC; Biesterfeld S; Galle PR; Holtmann MH
    World J Gastroenterol; 2008 Jul; 14(26):4156-67. PubMed ID: 18636661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants of vascular endothelial growth factor-D receptor binding and specificity.
    Leppänen VM; Jeltsch M; Anisimov A; Tvorogov D; Aho K; Kalkkinen N; Toivanen P; Ylä-Herttuala S; Ballmer-Hofer K; Alitalo K
    Blood; 2011 Feb; 117(5):1507-15. PubMed ID: 21148085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
    Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
    J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
    Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer].
    Chen YN; Gu Y
    Ai Zheng; 2009 Dec; 28(12):1337-43. PubMed ID: 19958632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
    Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Vascular Endothelial Growth Factor-D As a Targeted Therapy in Lymphedema Treatment: A Comprehensive Literature Review.
    Forte AJ; Boczar D; Huayllani MT; Anastasiadis PZ; McLaughlin SA
    Lymphat Res Biol; 2022 Feb; 20(1):3-6. PubMed ID: 33739868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.